In its preliminary report, Exactech announced a full year sales increase of 8 percent to $205.4 million in un-audited revenues. The company’s full year knee implant revenue increased by 5 percent to $80.1 million and hip implant revenues in creased 17 percent to $33.7 million. The largest growth was reported in the extremities business, which increased revenue by 33 percent to $39.9 million, which off-set the biologic and spine segment drop of 13 percent.
For the fourth quarter of 2011, the company reported a 21 percent decrease in biologic and spine revenue to $5.9 million and a 2 percent decrease in knee revenue to $20.1 million. However, extremities and hip implant revenues increased by 29 percent and 13 percent, respectively.
Related Articles on Orthopedic Implants:
Wright Medical Group Names Daniel Garen Senior Vice President, COO
ConforMIS Raises $89M for Future Development
12 Orthopedic & Spine Device Company Leadership Moves
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.